| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director +2 more
43 companies
Ra Capital Management, L.P. is a Director, 10% Owner at WVE with holdings across 43 companies. Recent SEC Form 4 filings include 19 buys and 0 sells.
Estimated insider holdings value: $3489.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 629,297 | $4.00 | $2,516,055.27 | +19.4% | +40.5% | -8.6% | |
| Dec 27, 2022 | FULC Fulcrum Therapeutics, Inc. | 10% Owner | Buy | 4,089 | $5.99 | $24,509.87 | - | -48.3% | +11.8% | |
| Dec 19, 2022 | FULC Fulcrum Therapeutics, Inc. | 10% Owner | Buy | 98,787 | $5.90 | $582,813.66 | +1.1% | -42.9% | -2.0% | |
| Dec 16, 2022 | FULC Fulcrum Therapeutics, Inc. | 10% Owner | Buy | 2,403,049 | $5.44 | $13,073,873.91 | +10.5% | -31.2% | +0.7% | |
| Dec 9, 2022 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 29,899 | $3.87 | $115,595.07 | +0.5% | +32.5% | -25.1% | |
| Nov 17, 2022 | ACRV Acrivon Therapeutics, Inc. | Director, 10% Owner | Buy | 3,389,500 | $12.50 | $42,368,750.00 | +340.8% | +43.1% | -75.3% | |
| Oct 24, 2022 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 85,902 | $3.92 | $336,811.50 | +0.9% | -6.0% | -29.5% | |
| Oct 19, 2022 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 506,197 | $3.68 | $1,860,961.40 | +6.0% | +4.7% | -20.9% | |
| Aug 4, 2022 | ANTX An2 Therapeutics, Inc. | 10% Owner | Buy | 1,909 | $7.51 | $14,330.32 | - | +71.4% | -5.5% | |
| Jul 27, 2022 | ANTX An2 Therapeutics, Inc. | 10% Owner | Buy | 23,219 | $7.78 | $180,674.69 | +0.3% | +90.0% | -1.1% |